This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
BELLUS Health Future Growth
Future criteria checks 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BELLUS Health.
Key information
46.1%
Earnings growth rate
41.4%
EPS growth rate
| Biotechs earnings growth | 36.3% |
| Revenue growth rate | 69.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 16 Jun 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 40 | -147 | -110 | -64 | 3 |
| 12/31/2024 | 0 | -141 | -130 | -127 | 3 |
| 12/31/2023 | 0 | -117 | -125 | -101 | 2 |
| 3/31/2023 | 0 | -87 | -89 | -89 | N/A |
| 12/31/2022 | 0 | -76 | -77 | -77 | N/A |
| 9/30/2022 | 0 | -73 | -68 | -68 | N/A |
| 6/30/2022 | 0 | -71 | -64 | -64 | N/A |
| 3/31/2022 | 0 | -70 | -60 | -60 | N/A |
| 12/31/2021 | 0 | -71 | -61 | -61 | N/A |
| 9/30/2021 | 0 | -64 | -49 | -49 | N/A |
| 6/30/2021 | 0 | -47 | -40 | -40 | N/A |
| 3/31/2021 | 0 | -37 | -36 | -36 | N/A |
| 12/31/2020 | 0 | -32 | -30 | -30 | N/A |
| 9/30/2020 | 0 | -34 | -30 | -30 | N/A |
| 6/30/2020 | 0 | -35 | -32 | -32 | N/A |
| 3/31/2020 | 0 | -33 | -29 | -29 | N/A |
| 12/31/2019 | 0 | -26 | -21 | -21 | N/A |
| 9/30/2019 | 0 | -18 | -14 | -14 | N/A |
| 6/30/2019 | 0 | -14 | -9 | -9 | N/A |
| 3/31/2019 | 0 | -9 | -8 | -8 | N/A |
| 12/31/2018 | 0 | -7 | -7 | -7 | N/A |
| 9/30/2018 | 0 | -6 | -7 | -7 | N/A |
| 6/30/2018 | 0 | -5 | -6 | -6 | N/A |
| 3/31/2018 | 0 | -4 | -5 | -5 | N/A |
| 12/31/2017 | 0 | -1 | -5 | -3 | N/A |
| 9/30/2017 | 0 | -1 | -4 | -3 | N/A |
| 6/30/2017 | 1 | 0 | -3 | -2 | N/A |
| 3/31/2017 | 1 | 0 | -3 | -2 | N/A |
| 12/31/2016 | 1 | -2 | N/A | -2 | N/A |
| 9/30/2016 | 3 | -1 | N/A | -2 | N/A |
| 6/30/2016 | 3 | 0 | N/A | -2 | N/A |
| 3/31/2016 | 3 | 0 | N/A | -2 | N/A |
| 12/31/2015 | 3 | 0 | N/A | -2 | N/A |
| 9/30/2015 | 2 | 0 | N/A | -2 | N/A |
| 6/30/2015 | 2 | -1 | N/A | -2 | N/A |
| 3/31/2015 | 2 | -1 | N/A | -2 | N/A |
| 12/31/2014 | 2 | -2 | N/A | -3 | N/A |
| 9/30/2014 | 2 | -2 | N/A | -3 | N/A |
| 6/30/2014 | 2 | -1 | N/A | -4 | N/A |
| 3/31/2014 | 2 | -1 | N/A | -3 | N/A |
| 12/31/2013 | 2 | -1 | N/A | -3 | N/A |
| 9/30/2013 | 2 | -1 | N/A | -3 | N/A |
| 6/30/2013 | 2 | -2 | N/A | -3 | N/A |
| 3/31/2013 | 2 | -10 | N/A | -3 | N/A |
| 12/31/2012 | 2 | -13 | N/A | -3 | N/A |
| 9/30/2012 | 3 | -15 | N/A | -2 | N/A |
| 6/30/2012 | 3 | -14 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0A4U is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0A4U is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0A4U is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0A4U's revenue (69% per year) is forecast to grow faster than the UK market (4.5% per year).
High Growth Revenue: 0A4U's revenue (69% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0A4U's Return on Equity is forecast to be high in 3 years time